Serimmune Inc.
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Website
- serimmune.com
- Founded
- 2014
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Epitope motifs from 3 causes of cerbral parasitiosis | CDC Pittsburgh | $45,750 |
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| Takeda Vaccines Inc. | HHSO100201600015C | $46,180 |
Grant awards
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| University Of Connecticut | R01AI182354 | $55,000 |
Quick answers
Is Serimmune Inc. registered in SAM.gov?
Serimmune Inc.'s SAM.gov registration expired on May 14, 2025.
What is Serimmune Inc.'s CAGE code?
Serimmune Inc.'s CAGE code is 78YZ7, and its Unique Entity ID (UEI) is QLNXP9AN7H58.
What is Serimmune Inc.'s most recent federal award?
Serimmune Inc.'s most recent federal grant award is Serum antibody biomarkers of myalgic encephalomyelitis/chronic fatigue syndrome (R43AI145696), from National Institute of Allergy and Infectious Diseases (NIH), on April 1, 2019.
On GovTribe
See Serimmune Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors